Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Performance Of Statistical And Machine Learning Risk Prediction Models For Advanced Breast Cancers.
  1. Home
  2. Performance Of Statistical And Machine Learning Risk Prediction Models For Advanced Breast Cancers.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative 10-year performance of mammography artificial intelligence, polygenic, and clinical breast cancer risk models in the Kaiser Permanente Research Bank.

Journal of the National Cancer Institute·2026
Same author

Individual-level trends in mammography screening over 14 years: results from an all-payer statewide claims database.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Patient- and Physician-Identified Considerations for Clinical Implementation of a New Risk-Based Prediction Tool to Guide Surveillance Mammography in Breast Cancer Survivors.

JCO oncology practice·2026
Same author

Regression methods for cost-effectiveness analysis with different censoring times or terminating events for survival time and costs.

Biometrics·2026
Same author

In what clinical settings are the MASAI trial results applicable?

Nature reviews. Clinical oncology·2026
Same author

Label-free fluorescence lifetime imaging for rapid discrimination of high-grade prostate cancer in fresh biopsy cores: a feasibility study.

Journal of biomedical optics·2026
Same journal

No association of prior administration of selected vaccines with lymphoma prognosis.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

A multi-state survival model to identify risk factors for lethal ovarian cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Development of the cf-MMSP assay for enhanced analytical sensitivity of methylated DNA in breast cancer liquid biopsy.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

The impact of adherence to cancer prevention recommendations on cancer incidence and mortality in a cohort of Canadian adults.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Energy Balance-Related Factors and Direct Tumor-Adipocyte Contact in Colorectal Cancer: Etiology Insights from the Population-Based Netherlands Cohort Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Radiation risk of screening-detected diffuse goiter in a Belarusian cohort exposed as children or adolescents to iodine-131 after Chernobyl.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
See all related articles

Related Experiment Video

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancers.

Shuai Chen1, Karla Kerlikowske2, Yu-Ru Su3

  • 1University of California, Davis Davis, CA United States.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
|May 14, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Regularized regression models showed similar accuracy but better calibration for predicting advanced breast cancer risk compared to machine learning methods. This approach offers a practical balance of performance and interpretability.

Related Experiment Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

  • Biostatistics
  • Medical Informatics
  • Oncology

Background:

  • Machine learning models offer complex risk prediction, but their performance relative to statistical methods is context-specific.
  • Advanced breast cancer risk prediction requires robust and reliable models.

Purpose of the Study:

  • To compare the performance of statistical and machine learning models in predicting advanced breast cancer risk.
  • To evaluate model calibration and discrimination using large-scale screening mammography data.

Main Methods:

  • Utilized data from 968,178 women (aged 40-74) from the Breast Cancer Surveillance Consortium (2005-2019).
  • Cross-validated logistic regression, regularized regressions (LASSO, Elastic net), random forests, and gradient boosting models.
  • Assessed model performance using calibration and area under the receiver operating characteristic curve (AUC).

Main Results:

  • All models demonstrated similar discrimination (AUC 0.677-0.690).
  • Regularized regressions achieved the most favorable calibration across all groups (AUC 0.689).
  • Gradient boosting showed comparable AUC but suboptimal calibration, while conventional logistic regression had slightly lower AUC and calibration.

Conclusions:

  • Regularized regression models provide similar discrimination and superior calibration for advanced breast cancer risk prediction.
  • Regularized regression offers a practical balance of performance and interpretability, especially for rare outcomes with limited features.